EMG
BLUE

Ellington Management Group’s bluebird bio BLUE Stock Holding History

Ellington Management Group’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-247
Closed -$281K – 556
2019
Q4 		$281K Buy
247
+62
+34% +$67.4K 0.06% 331
2019
Q3 		$220K Buy
185
+46
+33% +$70.2K 0.04% 466
2019
Q2 		$229K Buy
+139
New +$240K 0.04% 444
2016
Q4 		– Sell
-648
Closed -$569K – 556
2016
Q3 		$569K Buy
+648
New +$469K 0.16% 234
2015
Q3 		– Sell
-162
Closed -$354K – 715
2015
Q2 		$354K Buy
+162
New +$330K 0.09% 355

Other funds holding BLUE

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ellington Management Group's BLUE Position: Q1 2020 in Review

Ellington Management Group sold out of bluebird bio (BLUE) in Q1 2020, closing a stake of 247 shares — an estimated $281K sold.

Ellington Management Group first reported a position in BLUE in Q2 2015 and held it in 5 quarters. The position peaked at $569K in Q3 2016. 247 funds tracked by Wall St. Rank hold BLUE as of Q1 2020.

  • Ellington Management Group reported no remaining bluebird bio position as of Q1 2020 after selling out during the quarter.
  • Ellington Management Group sold 247 bluebird bio shares in Q1 2020, an estimated $281K.
  • Ellington Management Group first reported a position in bluebird bio in Q2 2015 and held it in 5 quarters.
  • Ellington Management Group's bluebird bio position peaked at $569K in Q3 2016.
  • 247 funds tracked by Wall St. Rank held bluebird bio as of Q1 2020.

Based on Ellington Management Group's 13F filing for Q1 2020, filed 15 May 2020.